AR048274A1 - Sintesis estereoselectiva de analogos de vitamina d - Google Patents

Sintesis estereoselectiva de analogos de vitamina d

Info

Publication number
AR048274A1
AR048274A1 ARP050101046A ARP050101046A AR048274A1 AR 048274 A1 AR048274 A1 AR 048274A1 AR P050101046 A ARP050101046 A AR P050101046A AR P050101046 A ARP050101046 A AR P050101046A AR 048274 A1 AR048274 A1 AR 048274A1
Authority
AR
Argentina
Prior art keywords
general structure
enriched
mixture
compounds
defined above
Prior art date
Application number
ARP050101046A
Other languages
English (en)
Spanish (es)
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of AR048274A1 publication Critical patent/AR048274A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP050101046A 2004-03-18 2005-03-17 Sintesis estereoselectiva de analogos de vitamina d AR048274A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55396204P 2004-03-18 2004-03-18
DKPA200400454 2004-03-22

Publications (1)

Publication Number Publication Date
AR048274A1 true AR048274A1 (es) 2006-04-12

Family

ID=34961016

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101046A AR048274A1 (es) 2004-03-18 2005-03-17 Sintesis estereoselectiva de analogos de vitamina d

Country Status (17)

Country Link
EP (1) EP1730108B1 (enExample)
JP (1) JP4667450B2 (enExample)
KR (1) KR100859277B1 (enExample)
CN (1) CN1934078B (enExample)
AR (1) AR048274A1 (enExample)
AT (1) ATE390411T1 (enExample)
BR (1) BRPI0507318A (enExample)
CA (1) CA2555260C (enExample)
CY (1) CY1108156T1 (enExample)
DE (2) DE05706821T1 (enExample)
ES (1) ES2304686T3 (enExample)
IL (1) IL176718A (enExample)
PL (1) PL1730108T3 (enExample)
RU (1) RU2380359C2 (enExample)
SI (1) SI1730108T1 (enExample)
TW (1) TWI324063B (enExample)
WO (1) WO2005087719A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2378252C2 (ru) * 2004-04-02 2010-01-10 Лео Фарма А/С Новый способ получения промежуточных соединений, применяемых для синтеза аналогов витамина d
EP1844010B1 (en) 2006-03-17 2013-02-13 Leo Pharma A/S Isomerisation of pharmaceutical intermediates
US8013189B2 (en) * 2007-09-21 2011-09-06 Basf Se Accelerated amide and ester reductions with amine boranes and additives
EP2299809B1 (en) * 2008-06-17 2018-10-17 Ben Gurion University Of The Negev R&D Authority Substituted cyclohexylidene-ethylidene-octahydro-indene compounds
CN103265528B (zh) * 2013-05-10 2015-05-06 湖南千金湘江药业股份有限公司 埃索美拉唑镁的制备方法
CN106908524B (zh) * 2015-12-23 2021-05-04 重庆华邦胜凯制药有限公司 卡泊三醇中间体l及其潜在基因毒性杂质的分离与测定方法
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
ES2945426B2 (es) * 2021-12-30 2024-01-22 Laboratorios Vinas S A Procedimiento para obtener epímeros 24S a partir de derivados de vitaminas D y procedimiento de obtención de vitaminas D relacionado

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866048A (en) * 1985-08-02 1989-09-12 Leo Pharmaceutical Products Ltd. Novel vitamin D analogues
JPH075542B2 (ja) * 1988-09-14 1995-01-25 呉羽化学工業株式会社 ビタミンｄ▲下３▼誘導体及びその製造方法
US5247104A (en) * 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
GB9300763D0 (en) * 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
US5449668A (en) * 1993-06-04 1995-09-12 Duphar International Research B.V. Vitamin D compounds and method of preparing these compounds
GB9524812D0 (en) * 1995-12-05 1996-02-07 Leo Pharm Prod Ltd Chemical compounds
GB9622590D0 (en) * 1996-10-30 1997-01-08 Leo Pharm Prod Ltd Chemical compounds
US6262283B1 (en) * 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
KR100676106B1 (ko) * 1998-10-23 2007-02-28 데이진 가부시키가이샤 비타민 ｄ3 유도체 및 그것을 사용하는 염증성 호흡기질환 치료제

Also Published As

Publication number Publication date
TW200539866A (en) 2005-12-16
PL1730108T3 (pl) 2008-09-30
EP1730108A1 (en) 2006-12-13
DE602005005645T2 (de) 2009-06-18
CN1934078B (zh) 2011-07-06
CN1934078A (zh) 2007-03-21
RU2006129922A (ru) 2008-02-27
KR100859277B1 (ko) 2008-09-19
ATE390411T1 (de) 2008-04-15
TWI324063B (en) 2010-05-01
DE05706821T1 (de) 2008-02-07
JP2007529433A (ja) 2007-10-25
JP4667450B2 (ja) 2011-04-13
CA2555260A1 (en) 2005-09-22
DE602005005645D1 (de) 2008-05-08
EP1730108B1 (en) 2008-03-26
IL176718A (en) 2007-07-04
ES2304686T3 (es) 2008-10-16
KR20060134045A (ko) 2006-12-27
RU2380359C2 (ru) 2010-01-27
SI1730108T1 (sl) 2008-08-31
BRPI0507318A (pt) 2007-06-26
CA2555260C (en) 2011-12-06
CY1108156T1 (el) 2014-02-12
WO2005087719A1 (en) 2005-09-22
HK1098122A1 (en) 2007-07-13

Similar Documents

Publication Publication Date Title
ECSP066858A (es) Inhibidores de gsk-3
CU23337B7 (es) Resolución de sal quiral
MX2010001605A (es) Metodo para producir olefinas fluoradas.
ECSP066406A (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
NI201100211A (es) Método mejorado para sintetizar pirfenidona
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
AR083483A2 (es) Proceso para la preparacion del citalopram racemico y del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
AR005010A1 (es) Metodo para convertir metanol a olefinas
CY1118836T1 (el) Αντι-ιϊκα φωσφονικα αναλογα
AR050496A1 (es) Catalizadores acidos solidos y metodos para utilizarlos
AR048274A1 (es) Sintesis estereoselectiva de analogos de vitamina d
PE20220169A1 (es) Compuestos macrociclicos como agonistas de sting
AR109669A1 (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano
AR069225A1 (es) Procedimiento de preparacion de compuestos morfinicos
BR0112848A (pt) Processos para a preparação de ácido r-lipóico ou de ácido s-lipóico, de ácido r-dihidrolipóico ou de ácido s-dihidrolipóico puros, e de sais farmacologicamente aceitáveis ou de derivados de ácido r-lipóico ou de ácido s-lipóico, e, composto
MY146099A (en) Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues
DE502004005133D1 (de) Verfahren zur herstellung von 4-fluor-1,3-dioxolan-2-on
EP1623982A4 (en) METHOD FOR PRODUCING DOCETAXEL TRIHYDRATE
ATE256108T1 (de) Verfahren zur herstellung von cholecalciferol- derivaten und zwischenverbindungen
AR048544A1 (es) Procedimiento para la preparacion de melamina pura
MY144065A (en) Epimerisation of allylic alcohols.
CO2024015540A2 (es) Métodos de flujo continuo para producir manosa-1-fosfato, polimorfos de manosa-1-fosfato y composiciones y usos relacionados con los mismos
AR111318A1 (es) Proceso para preparar 2-exo-(2-metilbenciloxi)-1-metil-4-isopropil-7-oxabiciclo[2.2.1]heptano
AR058284A1 (es) Proceso ajustable a escala para la preparacion de un 42- ester de rapamicina a partir de un boronato de 42- ester de rapamicina
AR051386A1 (es) Proceso para compuestos triciclicos que contienen atomos heterogeneos

Legal Events

Date Code Title Description
FB Suspension of granting procedure